In the last decades, several discoveries have uncovered the complexity of mammalian evolution during the Mesozoic Era, including important Gondwanan lineages: the australosphenidans, gondwanatherians, and meridiolestidans (Dryolestoidea). Most often, their presence and diversity is documented by isolated teeth and jaws. Here, we describe a new meridiolestidan mammal, Orretherium tzen gen. et sp. nov., from the Late Cretaceous of southern Chile, based on a partial jaw with five cheek teeth in locis and an isolated upper premolar. Phylogenetic analysis places Orretherium as the earliest divergence within Mesungulatidae, before other forms such as the Late Cretaceous Mesungulatum and Coloniatherium, and the early Paleocene Peligrotherium. The in loco tooth sequence (last two premolars and three molars) is the first recovered for a Cretaceous taxon in this family and suggests that reconstructed tooth sequences for other Mesozoic mesungulatids may include more than one species. Tooth eruption and replacement show that molar eruption in mesungulatids is heterochronically delayed with regard to basal dryolestoids, with therian-like simultaneous eruption of the last premolar and last molar. Meridiolestidans seem endemic to Patagonia, but given their diversity and abundance, and the similarity of vertebrate faunas in other regions of Gondwana, they may yet be discovered in other continents.
Recently, the morphology and encephalization of the brain endocast of the Triassic non-mammaliaform probainognathian cynodont Riograndia guaibensis were studied. Here, we analyzed the brain endocast of an additional specimen of this species.The new endocast shows well-defi ned olfactory bulbs and a median sulcus dividing the hemispheres, traits that were not clearly observed in the fi rst studied specimen.Encephalization quotients were also calculated, revealing similar values to other nonmammaliaform cynodonts and lower than those of the fi rst analyzed specimen. The analyzed cranium is slightly larger than the fi rst studied one and may represent an advanced ontogenetic stage. Hence, these differences may be related to the intraspecifi c variation of this cynodont or alternatively, to the preservation of each specimen.
Bone pathology in the titanosaur dinosaur Uberabatitan ribeiroi from the Marília Formation (Bauru Group, Late Cretaceous) of Uberaba city (Minas Gerais State, Brazil) is analysed here. They include two fused procoelous mid‐caudal vertebrae (CPPLIP‐1020) and a haemal arch (CPPLIP‐1006) of the middle section of the tail with a healing fracture callus. The analyses of the caudal vertebrae CPPLIP‐1020 of Uberabatitan permit us to recognize the following signs, based on CT scan and external macroscopic observations: (1) ossified longitudinal tendons; (2) likely ossified intervertebral disc, producing fused vertebral bodies; (3) fused right zygapophyseal process with a laterally developed osteophyte affecting this joint; (4) osteophytes and exostoses at different portions of the vertebrae; (5) cloacae, bone erosion and likely internal infection. According to all the processes observed in these caudals, we could not discard at least two possibilities for the diagnosis of the fused vertebrae. It could be the result of a spondyloarthropathy process (considering most of the observed signs) or possibly have been associated with an infection (e.g. discospondylitis/infections spondylitis or septic arthritis). The bone lesion record in Uberabatitan ribeiroi from the Late Cretaceous of Brazil increases the range of study of titanosaur dinosaurs, which although have a large fossil record, have few pathological studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.